ATE83926T1 - Antivirale anwendung von alpha-oligonucleotiden. - Google Patents

Antivirale anwendung von alpha-oligonucleotiden.

Info

Publication number
ATE83926T1
ATE83926T1 AT88909539T AT88909539T ATE83926T1 AT E83926 T1 ATE83926 T1 AT E83926T1 AT 88909539 T AT88909539 T AT 88909539T AT 88909539 T AT88909539 T AT 88909539T AT E83926 T1 ATE83926 T1 AT E83926T1
Authority
AT
Austria
Prior art keywords
inhibit
activity
compounds
antiviral use
reverse transcriptase
Prior art date
Application number
AT88909539T
Other languages
English (en)
Inventor
Jean-Louis Imbach
Bernard Rayner
Clerq Erik De
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE83926T1 publication Critical patent/ATE83926T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT88909539T 1987-10-14 1988-10-13 Antivirale anwendung von alpha-oligonucleotiden. ATE83926T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8714200A FR2621816B1 (fr) 1987-10-14 1987-10-14 Application antivirale des ologonucleotides
PCT/FR1988/000506 WO1989003217A1 (fr) 1987-10-14 1988-10-13 APPLICATION ANTIVIRALE DES OLIGONUCLEOTIDES alpha
EP88909539A EP0395672B1 (de) 1987-10-14 1988-10-13 Antivirale anwendung von alpha-oligonucleotiden

Publications (1)

Publication Number Publication Date
ATE83926T1 true ATE83926T1 (de) 1993-01-15

Family

ID=9355825

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88909539T ATE83926T1 (de) 1987-10-14 1988-10-13 Antivirale anwendung von alpha-oligonucleotiden.

Country Status (6)

Country Link
EP (1) EP0395672B1 (de)
JP (1) JPH03504004A (de)
AT (1) ATE83926T1 (de)
DE (1) DE3877212T2 (de)
FR (1) FR2621816B1 (de)
WO (1) WO1989003217A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2648045B1 (fr) * 1989-06-13 1991-09-27 Centre Nat Rech Scient Composes oligonucleotidiques anomeres alpha inhibant la replication des retrovirus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3125291A1 (de) * 1980-03-18 1983-01-27 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen Verwendung von 5-alkyl-pyrimidinnucleosiden als virostatika und arzneimittel mit virostatischer wirkung
FR2607507B1 (fr) * 1986-12-02 1990-04-13 Centre Nat Rech Scient Nouveaux derives a-d-oligonucleotides, leur preparation et leur emploi

Also Published As

Publication number Publication date
EP0395672A1 (de) 1990-11-07
DE3877212T2 (de) 1993-05-19
DE3877212D1 (de) 1993-02-11
EP0395672B1 (de) 1992-12-30
JPH03504004A (ja) 1991-09-05
FR2621816B1 (fr) 1990-12-28
FR2621816A1 (fr) 1989-04-21
WO1989003217A1 (fr) 1989-04-20

Similar Documents

Publication Publication Date Title
ATE315667T1 (de) Amplifizierung und detektion von hiv-1 und/oder hiv-2
ATE154029T1 (de) 7-deazapurin modifizierte oligonukleotide
DK605987A (da) Bestemte dna-sekvenser afledt af et papillomavirus-genom, deres anvendelse til in vitro diagnoseformaal og fremstilling af antigeniske praeparater bestemte dna-sekvenser afledt af et papillomavirus-genom, deres anvendelse til in vitro diagnoseformaal og fremstilling af antigeniske praeparater
DK0549615T3 (da) Sukkermodificerede oligonukleotider der påviser og modulerer genekspression
FI925103A0 (fi) Antisense-inhibitorer av humant immunbristvirus
DE3854297D1 (de) Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung.
ES2052591T3 (es) Variantes de virus lav, sus componentes de adn y de proteinas, y sus utilizaciones particularmente con fines diagnosticos y para la preparacion de composiciones inmunogenicas.
ATE146968T1 (de) Verwendung von funkionellen derivaten des interzellulär-adhäsions-moleküls icam-1 in einer antivirus-therapie
DK46787D0 (da) Antiviralt middel
ATE68349T1 (de) Medizinische verwendung von nukleosiden.
DE68912685D1 (de) Reinigung von Glucosaminoglucan abbauenden Enzymen.
BR9711647A (pt) Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os.
DE60015568D1 (de) Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür
ES548529A0 (es) Procedimiento de modificacion de celulas eucariotas.
DK615788A (da) Nucleosidforbindelser til anvendelse mod virale infektioner
IE893991L (en) 2',3'-dideoxypurine nucleoside/purine nucleoside¹phosphorylase inhibitor combination therapy and composition
ATE83926T1 (de) Antivirale anwendung von alpha-oligonucleotiden.
NO20000514D0 (no) Oligonukleotidprimere for effektiv multipleks deteksjon av Hepatitis C-virus (HCV) og human immunmangelvirus (HIV) og metoder for anvendelse derav
ATE272126T1 (de) Nachweis von retroviralen untertypen auf der basis der spezifischen sequenzen der hülle
ES2191842T3 (es) Interleucina-8 como agente antiviral y antitumoral.
DK0685235T3 (da) Ekstrakter af Piliostigma thonningii, anvendelse heraf og formuleringer, som indeholder dem
RU92016478A (ru) Способ диагностики гепатита, способ лечения гепатита
ATE82688T1 (de) Behandlung der menschlichen viralinfektion durch doppelstrang-rna, kombiniert mit viralen inhibitoren.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee